Patent Assignment
Reel/Frame 062388/0628
Change of Name
Recorded: 2023-01-13
Pages: 4
Assignor
LAM THERAPEUTICS, INC.
Executed: 2018-11-26
Assignee
AI THERAPEUTICS, INC.
530 OLD WHITFIELD STREET, GUILFORD, CONNECTICUT, 06437
Covered Property
(1)
Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension
Application:
17/965,859 →
Publication:
US 2023/0255944
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 13, 2023
From: ARMER, THOMAS; MELVIN, LAWRENCE S., JR.; ROTHBERG, JONATHAN M.; LICHENSTEIN, HENRI
To: LAM THERAPEUTICS, INC.
Reel/Frame 062372/0265 →
Change of Name
Oct 4, 2023
From: AI THERAPEUTICS, INC.
To: ORPHAI THERAPEUTICS INC.
Reel/Frame 065120/0663 →
Security Interest
Jun 23, 2025
From: ORPHAI THERAPEUTICS INC.
To: ACADIA WOODS PARTNERS, LLC
Reel/Frame 071697/0788 →
Security Interest
Feb 18, 2026
From: ORPHAI THERAPEUTICS INC.
To: ACADIA WOODS PARTNERS, LLC, AS AGENT
Reel/Frame 074910/0274 →